Skip to main content
Erschienen in: Clinical Rheumatology 7/2019

26.02.2019 | Original Article

Prevalence of frailty and its associated factors in patients with rheumatoid arthritis: a cross-sectional analysis

verfasst von: Fausto Salaffi, Marco Di Carlo, Sonia Farah, Eleonora Di Donato, Marina Carotti

Erschienen in: Clinical Rheumatology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aims of the present research were to assess the prevalence of frailty and its potential associated factors in a cohort of adult patients with rheumatoid arthritis (RA).

Methods

Consecutive RA patients and healthy controls were assessed according to the Survey of Health, Ageing and Retirement in Europe Frailty Instrument (SHARE-FI), and classified as frail, pre-frail, or non-frail. Chi-square, analysis of variance (ANOVA), and multinomial logistic regression analyses were used to test the prognostic value of frailty for the outcomes of interest.

Results

Two hundred and ten consecutive RA patients (65.7% female, mean age 60.4 years) and 100 healthy controls (63% female, mean age 59.1 years) were included. According to SHARE-FI criteria, 35 RA patients (16.6%) were categorized as frail, 68 (32.4%) as pre-frail, and 107 (51%) as non-frail, while 8 control subjects were categorized as frail, (8%), 17 as pre-frail (17%), and 75 as non-frail (75%) (chi-squared 12.8; P = 0.0016). The results from logistic regression analysis revealed that age (odds ratio [OR] = 1.12, 95% confidence interval [CI] = 1.07–1.17; P < 0.0001), comorbidities (OR = 1.51, 95% CI = 1.01–2.27; P = 0.0446), and high disease activity (OR = 1.10, 95% CI = 1.04–1.16; P = 0.0006) were independently associated with frailty in RA.

Conclusions

Frailty or pre-frailty are common in RA. The SHARE-FI may be a useful tool for the screening of frailty in RA and may summarize the results of a comprehensive RA assessment providing a marker of deficits accumulation.
Literatur
1.
2.
Zurück zum Zitat Baker JF, Von Feldt J, Mostoufi-Moab S et al (2014) Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis. Arthritis Care Res 66:1612–1618CrossRef Baker JF, Von Feldt J, Mostoufi-Moab S et al (2014) Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis. Arthritis Care Res 66:1612–1618CrossRef
3.
Zurück zum Zitat Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM (2008) Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 59:1407–1415CrossRefPubMedPubMedCentral Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM (2008) Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 59:1407–1415CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kramer HR, Fontaine KR, Bathon JM, Giles JT (2012) Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum 64:2438–2450CrossRefPubMedPubMedCentral Kramer HR, Fontaine KR, Bathon JM, Giles JT (2012) Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum 64:2438–2450CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E (2016) Role of sleep disturbance, depression, obesity, and physical inactivity in fatigue in rheumatoid arthritis. Arthritis Care Res 68:81–90CrossRef Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E (2016) Role of sleep disturbance, depression, obesity, and physical inactivity in fatigue in rheumatoid arthritis. Arthritis Care Res 68:81–90CrossRef
8.
Zurück zum Zitat Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156CrossRefPubMed Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156CrossRefPubMed
9.
Zurück zum Zitat Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487–1492CrossRefPubMed Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487–1492CrossRefPubMed
10.
Zurück zum Zitat Andrews JS, Trupin L, Yelin EH, Hough CL, Covinsky KE, Katz PP (2017) Frailty and reduced physical function go hand in hand in adults with rheumatoid arthritis: a US observational cohort study. Clin Rheumatol 36:1031–1039CrossRefPubMedPubMedCentral Andrews JS, Trupin L, Yelin EH, Hough CL, Covinsky KE, Katz PP (2017) Frailty and reduced physical function go hand in hand in adults with rheumatoid arthritis: a US observational cohort study. Clin Rheumatol 36:1031–1039CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed
12.
Zurück zum Zitat Salaffi F, Carotti M, Gutierrez M, Di Carlo M, De Angelis R (2015) Patient acceptable symptom state in self-report questionnaires and composite clinical disease index for assessing rheumatoid arthritis activity: identification of cut-off points for routine care. Biomed Res Int 2015:930756PubMedPubMedCentral Salaffi F, Carotti M, Gutierrez M, Di Carlo M, De Angelis R (2015) Patient acceptable symptom state in self-report questionnaires and composite clinical disease index for assessing rheumatoid arthritis activity: identification of cut-off points for routine care. Biomed Res Int 2015:930756PubMedPubMedCentral
13.
Zurück zum Zitat Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145CrossRefPubMed Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145CrossRefPubMed
14.
Zurück zum Zitat van der Heijde D, Dankert T, Nieman F, Rau R, Boers M (1999) Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford) 38:941–947CrossRef van der Heijde D, Dankert T, Nieman F, Rau R, Boers M (1999) Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford) 38:941–947CrossRef
15.
Zurück zum Zitat Spaetgens B, Wijnands JM, van Durme C, Boonen A (2015) Content and construct validity of the Rheumatic Diseases Comorbidity Index in patients with gout. Rheumatology (Oxford) 54:1659–1663CrossRef Spaetgens B, Wijnands JM, van Durme C, Boonen A (2015) Content and construct validity of the Rheumatic Diseases Comorbidity Index in patients with gout. Rheumatology (Oxford) 54:1659–1663CrossRef
16.
Zurück zum Zitat Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J (2009) Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 64:675–681CrossRefPubMed Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J (2009) Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 64:675–681CrossRefPubMed
17.
Zurück zum Zitat De Lepeleire J, Degryse J, Illiffe S, Mann E, Buntinx F (2008) Family physicians need easy instruments for frailty. Age Ageing 37:484 author reply 484-485CrossRefPubMed De Lepeleire J, Degryse J, Illiffe S, Mann E, Buntinx F (2008) Family physicians need easy instruments for frailty. Age Ageing 37:484 author reply 484-485CrossRefPubMed
18.
Zurück zum Zitat Romero-Ortuno R, Walsh CD, Lawlor BA, Kenny RA (2010) A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr 10:57CrossRefPubMedPubMedCentral Romero-Ortuno R, Walsh CD, Lawlor BA, Kenny RA (2010) A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr 10:57CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in older people. Lancet 381:752–762CrossRefPubMed Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in older people. Lancet 381:752–762CrossRefPubMed
20.
Zurück zum Zitat Morley JE, Perry HM, Miller DK (2002) Something about frailty. J Gerontol A Biol Sci Med Sci 57:698–704CrossRef Morley JE, Perry HM, Miller DK (2002) Something about frailty. J Gerontol A Biol Sci Med Sci 57:698–704CrossRef
21.
Zurück zum Zitat European Commission (2013) In: European Commission (ed) EU employment and social situation, quarterly review, special supplement on demographic trends, Brussels European Commission (2013) In: European Commission (ed) EU employment and social situation, quarterly review, special supplement on demographic trends, Brussels
22.
Zurück zum Zitat Gomez CR, Boehmer ED, Kovacs EJ (2005) The aging innate immune system. Curr Opin Immunol 17:457–462CrossRefPubMed Gomez CR, Boehmer ED, Kovacs EJ (2005) The aging innate immune system. Curr Opin Immunol 17:457–462CrossRefPubMed
23.
Zurück zum Zitat Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM III, Hunder GG, Therneau TM, Gabriel SE (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63:633–639CrossRefPubMedPubMedCentral Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM III, Hunder GG, Therneau TM, Gabriel SE (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63:633–639CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Mulasso A, Roppolo M, Giannotta F, Rabaglietti E (2016) Associations of frailty and psychosocial factors with autonomy in daily activities: a cross-sectional study in Italian community-dwelling older adults. Clin Interv Aging 11:37–45PubMedPubMedCentral Mulasso A, Roppolo M, Giannotta F, Rabaglietti E (2016) Associations of frailty and psychosocial factors with autonomy in daily activities: a cross-sectional study in Italian community-dwelling older adults. Clin Interv Aging 11:37–45PubMedPubMedCentral
25.
Zurück zum Zitat Castell MV, van der Pas S, Otero A, Siviero P, Dennison E, Denkinger M, Pedersen N, Sanchez-Martinez M, Queipo R, van Schoor N, Zambon S, Edwards M, Peter R, Schaap L, Deeg D (2015) Osteoarthritis and frailty in elderly individuals across six European countries: results from the European Project on OSteoArthritis (EPOSA). BMC Musculoskelet Disord 16:359CrossRefPubMedPubMedCentral Castell MV, van der Pas S, Otero A, Siviero P, Dennison E, Denkinger M, Pedersen N, Sanchez-Martinez M, Queipo R, van Schoor N, Zambon S, Edwards M, Peter R, Schaap L, Deeg D (2015) Osteoarthritis and frailty in elderly individuals across six European countries: results from the European Project on OSteoArthritis (EPOSA). BMC Musculoskelet Disord 16:359CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, Orwoll ES, for the Osteoporotic Fractures in Men Research Group (2007) Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 55:1216–1223CrossRefPubMed Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, Orwoll ES, for the Osteoporotic Fractures in Men Research Group (2007) Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 55:1216–1223CrossRefPubMed
28.
Zurück zum Zitat Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP (2006) Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci 61:262–266CrossRefPubMed Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP (2006) Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci 61:262–266CrossRefPubMed
29.
Zurück zum Zitat Evans WJ (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91:1123S–1127SCrossRefPubMed Evans WJ (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91:1123S–1127SCrossRefPubMed
30.
Zurück zum Zitat Biolo G, Cederholm T, Muscaritoli M (2014) Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr 33:737–748CrossRefPubMed Biolo G, Cederholm T, Muscaritoli M (2014) Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr 33:737–748CrossRefPubMed
31.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 39:412–423CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 39:412–423CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Higgins SC, Adams J, Hughes R (2018) Measuring hand grip strength in rheumatoid arthritis. Rheumatol Int 38:707–714CrossRefPubMed Higgins SC, Adams J, Hughes R (2018) Measuring hand grip strength in rheumatoid arthritis. Rheumatol Int 38:707–714CrossRefPubMed
33.
Zurück zum Zitat Svens B, Lee H (2005) Intra- and inter-instrument reliability of grip-strength measurements: GripTrack™ and Jamar® hand dynamometers. Hand Ther 10:47–55CrossRef Svens B, Lee H (2005) Intra- and inter-instrument reliability of grip-strength measurements: GripTrack™ and Jamar® hand dynamometers. Hand Ther 10:47–55CrossRef
34.
Zurück zum Zitat Vliet Vlieland TP, van der Wijk TP, Jolie IM, Zwinderman AH, Hazes JM (1996) Determinants of hand function in patients with rheumatoid arthritis. J Rheumatol 23:835–840PubMed Vliet Vlieland TP, van der Wijk TP, Jolie IM, Zwinderman AH, Hazes JM (1996) Determinants of hand function in patients with rheumatoid arthritis. J Rheumatol 23:835–840PubMed
35.
Zurück zum Zitat Björk MA, Thyberg IS, Skogh T, Gerdle BU (2007) Hand function and activity limitation according to health assessment questionnaire in patients with rheumatoid arthritis and healthy referents: 5-year followup of predictors of activity limitation (The Swedish TIRA Project). J Rheumatol 34:296–302PubMed Björk MA, Thyberg IS, Skogh T, Gerdle BU (2007) Hand function and activity limitation according to health assessment questionnaire in patients with rheumatoid arthritis and healthy referents: 5-year followup of predictors of activity limitation (The Swedish TIRA Project). J Rheumatol 34:296–302PubMed
36.
Zurück zum Zitat Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos G (2004) Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol 31:58–65PubMed Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos G (2004) Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol 31:58–65PubMed
37.
Zurück zum Zitat Gabriel SE, Crowson CS, O’Fallon WM (1999) Comorbidity in arthritis. J Rheumatol 26:2475–2479PubMed Gabriel SE, Crowson CS, O’Fallon WM (1999) Comorbidity in arthritis. J Rheumatol 26:2475–2479PubMed
38.
Zurück zum Zitat England BR, Sayles H, Mikuls TR, Johnson DS, Michaud K (2015) Validation of the rheumatic disease comorbidity index. Arthritis Care Res 67:865–872CrossRef England BR, Sayles H, Mikuls TR, Johnson DS, Michaud K (2015) Validation of the rheumatic disease comorbidity index. Arthritis Care Res 67:865–872CrossRef
39.
Zurück zum Zitat Iannone F, Salaffi F, Fornaro M et al (2018) Influence of baseline modified rheumatic disease comorbidity index (mRDCI) on drug survival and effectiveness of biological drugs in patients affected with rheumatoid arthritis (RA), spondyloarthritis (SPA), and psoriatic arthritis (PSA) in real-world settings. Eur J Clin Investig 48:e13013CrossRef Iannone F, Salaffi F, Fornaro M et al (2018) Influence of baseline modified rheumatic disease comorbidity index (mRDCI) on drug survival and effectiveness of biological drugs in patients affected with rheumatoid arthritis (RA), spondyloarthritis (SPA), and psoriatic arthritis (PSA) in real-world settings. Eur J Clin Investig 48:e13013CrossRef
40.
Zurück zum Zitat Franceschi C, Bonafe’ M, Valensin S et al (2000) Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254CrossRefPubMed Franceschi C, Bonafe’ M, Valensin S et al (2000) Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254CrossRefPubMed
41.
Zurück zum Zitat Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326–M332CrossRefPubMed Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57:M326–M332CrossRefPubMed
42.
Zurück zum Zitat Leng S, Chaves P, Koenig K, Walston J (2002) Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50:1268–1271CrossRefPubMed Leng S, Chaves P, Koenig K, Walston J (2002) Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50:1268–1271CrossRefPubMed
43.
Zurück zum Zitat Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE (2000) Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 55:M709–M715CrossRefPubMed Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE (2000) Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 55:M709–M715CrossRefPubMed
Metadaten
Titel
Prevalence of frailty and its associated factors in patients with rheumatoid arthritis: a cross-sectional analysis
verfasst von
Fausto Salaffi
Marco Di Carlo
Sonia Farah
Eleonora Di Donato
Marina Carotti
Publikationsdatum
26.02.2019
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 7/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04486-5

Weitere Artikel der Ausgabe 7/2019

Clinical Rheumatology 7/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.